BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 21376256)

  • 1. Bcl-2 upregulation induced by miR-21 via a direct interaction is associated with apoptosis and chemoresistance in MIA PaCa-2 pancreatic cancer cells.
    Dong J; Zhao YP; Zhou L; Zhang TP; Chen G
    Arch Med Res; 2011 Jan; 42(1):8-14. PubMed ID: 21376256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regarding article 'Bcl-2 upregulation induced by miR-21 via a direct interaction is associated with apoptosis and chemoresistance in MIA PaCa-2 pancreatic cancer cells'.
    Pan TH; Wu XY
    Arch Med Res; 2012 Apr; 43(3):252; author reply 253. PubMed ID: 22560983
    [No Abstract]   [Full Text] [Related]  

  • 3. MiR-608 regulating the expression of ribonucleotide reductase M1 and cytidine deaminase is repressed through induced gemcitabine chemoresistance in pancreatic cancer cells.
    Rajabpour A; Afgar A; Mahmoodzadeh H; Radfar JE; Rajaei F; Teimoori-Toolabi L
    Cancer Chemother Pharmacol; 2017 Oct; 80(4):765-775. PubMed ID: 28887583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemosensitization and inhibition of pancreatic cancer stem cell proliferation by overexpression of microRNA-205.
    Chaudhary AK; Mondal G; Kumar V; Kattel K; Mahato RI
    Cancer Lett; 2017 Aug; 402():1-8. PubMed ID: 28536008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miRNA-181b increases the sensitivity of pancreatic ductal adenocarcinoma cells to gemcitabine in vitro and in nude mice by targeting BCL-2.
    Cai B; An Y; Lv N; Chen J; Tu M; Sun J; Wu P; Wei J; Jiang K; Miao Y
    Oncol Rep; 2013 May; 29(5):1769-76. PubMed ID: 23440261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alteration of the intrinsic apoptosis pathway is involved in Notch-induced chemoresistance to gemcitabine in pancreatic cancer.
    Du X; Zhao YP; Zhang TP; Zhou L; Chen G; Wang TX; You L; Shu H
    Arch Med Res; 2014 Jan; 45(1):15-20. PubMed ID: 24316112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resistance of pancreatic cancer to gemcitabine treatment is dependent on mitochondria-mediated apoptosis.
    Schniewind B; Christgen M; Kurdow R; Haye S; Kremer B; Kalthoff H; Ungefroren H
    Int J Cancer; 2004 Mar; 109(2):182-8. PubMed ID: 14750167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-29c Increases the Chemosensitivity of Pancreatic Cancer Cells by Inhibiting USP22 Mediated Autophagy.
    Huang L; Hu C; Cao H; Wu X; Wang R; Lu H; Li H; Chen H
    Cell Physiol Biochem; 2018; 47(2):747-758. PubMed ID: 29807360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acquired resistance of pancreatic cancer cells towards 5-Fluorouracil and gemcitabine is associated with altered expression of apoptosis-regulating genes.
    Shi X; Liu S; Kleeff J; Friess H; Büchler MW
    Oncology; 2002; 62(4):354-62. PubMed ID: 12138244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-17-5p inhibitor enhances chemosensitivity to gemcitabine via upregulating Bim expression in pancreatic cancer cells.
    Yan HJ; Liu WS; Sun WH; Wu J; Ji M; Wang Q; Zheng X; Jiang JT; Wu CP
    Dig Dis Sci; 2012 Dec; 57(12):3160-7. PubMed ID: 23001407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. pERK1/2 silencing sensitizes pancreatic cancer BXPC-3 cell to gemcitabine-induced apoptosis via regulating Bax and Bcl-2 expression.
    Wang M; Lu X; Dong X; Hao F; Liu Z; Ni G; Chen D
    World J Surg Oncol; 2015 Feb; 13():66. PubMed ID: 25880226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-21 upregulation induced by promoter zone histone acetylation is associated with chemoresistance to gemcitabine and enhanced malignancy of pancreatic cancer cells.
    Song WF; Wang L; Huang WY; Cai X; Cui JJ; Wang LW
    Asian Pac J Cancer Prev; 2013; 14(12):7529-36. PubMed ID: 24460329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [MiR-150-5p inhibits the proliferation and promoted apoptosis of pancreatic cancer cells].
    Sun Y; Jin XL; Zhang TT; Jia CW; Chen J
    Zhonghua Bing Li Xue Za Zhi; 2013 Jul; 42(7):460-4. PubMed ID: 24246865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TIMP1 down-regulation enhances gemcitabine sensitivity and reverses chemoresistance in pancreatic cancer.
    Tan Y; Li X; Tian Z; Chen S; Zou J; Lian G; Chen S; Huang K; Chen Y
    Biochem Pharmacol; 2021 Jul; 189():114085. PubMed ID: 32522594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Double inhibition of NF-κB and XIAP via RNAi enhances the sensitivity of pancreatic cancer cells to gemcitabine.
    Cao LP; Song JL; Yi XP; Li YX
    Oncol Rep; 2013 Apr; 29(4):1659-65. PubMed ID: 23354694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. β2-adrenoceptor blocker synergizes with gemcitabine to inhibit the proliferation of pancreatic cancer cells via apoptosis induction.
    Shan T; Ma Q; Zhang D; Guo K; Liu H; Wang F; Wu E
    Eur J Pharmacol; 2011 Aug; 665(1-3):1-7. PubMed ID: 21570961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Restoration of transforming growth factor-beta signaling enhances radiosensitivity by altering the Bcl-2/Bax ratio in the p53 mutant pancreatic cancer cell line MIA PaCa-2.
    Ahmed MM; Alcock RA; Chendil D; Dey S; Das A; Venkatasubbarao K; Mohiuddin M; Sun L; Strodel WE; Freeman JW
    J Biol Chem; 2002 Jan; 277(3):2234-46. PubMed ID: 11694525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resveratrol induces apoptosis of pancreatic cancers cells by inhibiting miR-21 regulation of BCL-2 expression.
    Liu P; Liang H; Xia Q; Li P; Kong H; Lei P; Wang S; Tu Z
    Clin Transl Oncol; 2013 Sep; 15(9):741-6. PubMed ID: 23359184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leptin-elicited miRNA-342-3p potentiates gemcitabine resistance in pancreatic ductal adenocarcinoma.
    Ma L; Fan Z; Du G; Wang H
    Biochem Biophys Res Commun; 2019 Feb; 509(3):845-853. PubMed ID: 30638935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Garcinol sensitizes human pancreatic adenocarcinoma cells to gemcitabine in association with microRNA signatures.
    Parasramka MA; Ali S; Banerjee S; Deryavoush T; Sarkar FH; Gupta S
    Mol Nutr Food Res; 2013 Feb; 57(2):235-48. PubMed ID: 23293055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.